Hide Filters
Showing 2976 results

  • LGBTQI+ inclusion

  • Benefits & Rewards

  • Event / May 30, 2025

    ASCO 2025

    At this year’s American Society of Clinical Oncology Annual Meeting (ASCO), we will be sharing the latest oncology portfolio data, research, and science around how we are reimagining medicine.Learn…
  • Press release /

    Novartis announces commencement of tender offer to acquire Regulus Therapeutics

    Basel, May 27, 2025 - Novartis today announced that Redwood Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis (“Purchaser”), has commenced a tender offer to…
  • Featured News /

    Novartis R&D Day

    Novartis shares progress in advancing its industry-leading R&D pipeline. We are uniquely positioned to deliver transformational treatments through our scale, focus on innovative medicines, diverse range of therapeutic areas and exposure to cutting-edge platforms.

  • The Program lead of ‘Ensemble’ sitting with a Novartis employee and caregiver
    Story /

    Reimagining cancer in the workplace

    People and Culture

    Novartis is strongly committed in helping and supporting employees impacted by cancer through the program Ensemble – Caring for Colleagues (Ensemble).

  • Special Olympian Ryan Groves suffers from TSC, a genetic condition that afflicts nearly 1 million patients worldwide.
    Story /

    With a "brain in a dish," researchers take on neurological disorders

    From Our Labs

    Neurological diseases develop out of sight. Novartis neuroscientists are bringing them into the light, using human brain cells grown in the lab.

  • Dr. Botond Roska shares his thoughts on the future of gene therapy.
    Story /

    Bringing gene therapy into focus

    Discovery

    Dr. Botond Roska says we should keep our eyes on gene therapy.

  • Featured News /

    Why healthcare’s digital moment is now

  • Featured News /

    New report shows how AI in health is critical for COVID-19 response and recovery